An van Es-Johansson

An van Es-Johansson joined the Board in January 2020. Dr. van Es-Johansson currently serves as a Senior Advisor for AlzeCure Pharma, a Swedish pharmaceutical company with a primary focus on Alzheimer’s disease, where she is responsible for regulatory, clinical development, clinical operations, and pharmacovigilance. From 2005-2018, Dr. van Es-Johansson served in a range of executive roles of increasing responsibility at Swedish Orphan Biovitrum AB (Sobi), an international specialty biopharmaceutical company focused on rare diseases. Dr. van Es-Johansson has leadership experience within large pharmaceutical and smaller biotechnology companies, including Roche, Eli Lilly, Active Biotech, and BioStratum. She currently serves on the Board of Directors at Lumos Pharma, Medivir AB, Agendia Inc., and Savara Inc. Dr. van Es-Johansson received a M.D. from Erasmus University in Rotterdam, The Netherlands.